U.S. Physical Therapy, Inc. (NYSE:USPH) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $97.50.

USPH has been the subject of several analyst reports. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Citizens Jmp reissued a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Finally, Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th.

U.S. Physical Therapy Price Performance

NYSE USPH opened at $71.41 on Thursday. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $93.50. The stock’s 50-day moving average is $65.31 and its two-hundred day moving average is $74.88. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19. The firm has a market cap of $1.09 billion, a P/E ratio of 142.81, a price-to-earnings-growth ratio of 1.94 and a beta of 1.15.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). The company had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The business’s revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.48 EPS. On average, analysts anticipate that U.S. Physical Therapy will post 2.99 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 22nd were given a dividend of $0.46 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.84 dividend on an annualized basis and a yield of 2.6%. U.S. Physical Therapy’s payout ratio is currently 368.00%.

Insider Transactions at U.S. Physical Therapy

In other news, Director Peter Francis Minan purchased 492 shares of the firm’s stock in a transaction on Monday, June 8th. The stock was bought at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Several large investors have recently made changes to their positions in USPH. Vanguard Group Inc. grew its holdings in U.S. Physical Therapy by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 1,085,336 shares of the company’s stock valued at $84,754,000 after buying an additional 15,712 shares during the last quarter. Copeland Capital Management LLC increased its position in U.S. Physical Therapy by 6.5% in the 1st quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock worth $62,729,000 after buying an additional 50,717 shares during the period. Bank of America Corp DE lifted its holdings in shares of U.S. Physical Therapy by 10.9% during the first quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock worth $41,574,000 after buying an additional 54,656 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of U.S. Physical Therapy by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company’s stock worth $38,035,000 after buying an additional 15,668 shares during the last quarter. Finally, William Blair Investment Management LLC boosted its position in shares of U.S. Physical Therapy by 7.2% in the fourth quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock valued at $28,949,000 after acquiring an additional 24,848 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.